Recurrent or refractory trigeminal neuralgia after microvascular decompression, radiofrequency ablation, or radiosurgery.

Rene O. Sanchez-Mejia, Mary Limbo, Jason S. Cheng, Joaquin Camara, Mariann M. Ward, Nicholas Barbaro

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

OBJECT: Trigeminal neuralgia (TN) is characterized by paroxysmal lancinating pain in the trigeminal nerve distribution. When TN is refractory to medical management, patients are referred for microvascular decompression (MVD), radiofrequency ablation, or radiosurgery. After the initial treatment, patients may have refractory or recurrent symptoms requiring retreatment. The purpose of this study was to determine what factors are associated with the need for retreatment and which modality is most effective. METHODS: To define this population further, the authors evaluated a cohort of patients who required retreatment for TN. The mean follow-up periods were 51 months from the first treatment and 23 months from the last one, and these were comparable among treatment groups. CONCLUSIONS: Trigeminal neuralgia can recur after neurosurgical treatment. In this study the authors demonstrate that the number of patients requiring retreatment is not negligible. Lower retreatment rates were seen in patients who initially underwent radiosurgery, compared with those in whom MVD or radiofrequency ablation were performed. Radiosurgery was more likely to be the final treatment for recurrent TN regardless of the initial treatment. After retreatment, the majority of patients attained complete or very good pain relief. Pain relief after retreatment correlates with postoperative facial numbness.

Original languageEnglish (US)
JournalNeurosurgical Focus
Volume18
Issue number5
StatePublished - 2005
Externally publishedYes

Fingerprint

Microvascular Decompression Surgery
Trigeminal Neuralgia
Retreatment
Radiosurgery
Pain
Therapeutics
Trigeminal Nerve
Hypesthesia

Cite this

Sanchez-Mejia, R. O., Limbo, M., Cheng, J. S., Camara, J., Ward, M. M., & Barbaro, N. (2005). Recurrent or refractory trigeminal neuralgia after microvascular decompression, radiofrequency ablation, or radiosurgery. Neurosurgical Focus, 18(5).

Recurrent or refractory trigeminal neuralgia after microvascular decompression, radiofrequency ablation, or radiosurgery. / Sanchez-Mejia, Rene O.; Limbo, Mary; Cheng, Jason S.; Camara, Joaquin; Ward, Mariann M.; Barbaro, Nicholas.

In: Neurosurgical Focus, Vol. 18, No. 5, 2005.

Research output: Contribution to journalArticle

Sanchez-Mejia, RO, Limbo, M, Cheng, JS, Camara, J, Ward, MM & Barbaro, N 2005, 'Recurrent or refractory trigeminal neuralgia after microvascular decompression, radiofrequency ablation, or radiosurgery.', Neurosurgical Focus, vol. 18, no. 5.
Sanchez-Mejia, Rene O. ; Limbo, Mary ; Cheng, Jason S. ; Camara, Joaquin ; Ward, Mariann M. ; Barbaro, Nicholas. / Recurrent or refractory trigeminal neuralgia after microvascular decompression, radiofrequency ablation, or radiosurgery. In: Neurosurgical Focus. 2005 ; Vol. 18, No. 5.
@article{b3db23de2043416fb481d3cdd683a3d4,
title = "Recurrent or refractory trigeminal neuralgia after microvascular decompression, radiofrequency ablation, or radiosurgery.",
abstract = "OBJECT: Trigeminal neuralgia (TN) is characterized by paroxysmal lancinating pain in the trigeminal nerve distribution. When TN is refractory to medical management, patients are referred for microvascular decompression (MVD), radiofrequency ablation, or radiosurgery. After the initial treatment, patients may have refractory or recurrent symptoms requiring retreatment. The purpose of this study was to determine what factors are associated with the need for retreatment and which modality is most effective. METHODS: To define this population further, the authors evaluated a cohort of patients who required retreatment for TN. The mean follow-up periods were 51 months from the first treatment and 23 months from the last one, and these were comparable among treatment groups. CONCLUSIONS: Trigeminal neuralgia can recur after neurosurgical treatment. In this study the authors demonstrate that the number of patients requiring retreatment is not negligible. Lower retreatment rates were seen in patients who initially underwent radiosurgery, compared with those in whom MVD or radiofrequency ablation were performed. Radiosurgery was more likely to be the final treatment for recurrent TN regardless of the initial treatment. After retreatment, the majority of patients attained complete or very good pain relief. Pain relief after retreatment correlates with postoperative facial numbness.",
author = "Sanchez-Mejia, {Rene O.} and Mary Limbo and Cheng, {Jason S.} and Joaquin Camara and Ward, {Mariann M.} and Nicholas Barbaro",
year = "2005",
language = "English (US)",
volume = "18",
journal = "Neurosurgical Focus",
issn = "1092-0684",
publisher = "American Association of Neurological Surgeons",
number = "5",

}

TY - JOUR

T1 - Recurrent or refractory trigeminal neuralgia after microvascular decompression, radiofrequency ablation, or radiosurgery.

AU - Sanchez-Mejia, Rene O.

AU - Limbo, Mary

AU - Cheng, Jason S.

AU - Camara, Joaquin

AU - Ward, Mariann M.

AU - Barbaro, Nicholas

PY - 2005

Y1 - 2005

N2 - OBJECT: Trigeminal neuralgia (TN) is characterized by paroxysmal lancinating pain in the trigeminal nerve distribution. When TN is refractory to medical management, patients are referred for microvascular decompression (MVD), radiofrequency ablation, or radiosurgery. After the initial treatment, patients may have refractory or recurrent symptoms requiring retreatment. The purpose of this study was to determine what factors are associated with the need for retreatment and which modality is most effective. METHODS: To define this population further, the authors evaluated a cohort of patients who required retreatment for TN. The mean follow-up periods were 51 months from the first treatment and 23 months from the last one, and these were comparable among treatment groups. CONCLUSIONS: Trigeminal neuralgia can recur after neurosurgical treatment. In this study the authors demonstrate that the number of patients requiring retreatment is not negligible. Lower retreatment rates were seen in patients who initially underwent radiosurgery, compared with those in whom MVD or radiofrequency ablation were performed. Radiosurgery was more likely to be the final treatment for recurrent TN regardless of the initial treatment. After retreatment, the majority of patients attained complete or very good pain relief. Pain relief after retreatment correlates with postoperative facial numbness.

AB - OBJECT: Trigeminal neuralgia (TN) is characterized by paroxysmal lancinating pain in the trigeminal nerve distribution. When TN is refractory to medical management, patients are referred for microvascular decompression (MVD), radiofrequency ablation, or radiosurgery. After the initial treatment, patients may have refractory or recurrent symptoms requiring retreatment. The purpose of this study was to determine what factors are associated with the need for retreatment and which modality is most effective. METHODS: To define this population further, the authors evaluated a cohort of patients who required retreatment for TN. The mean follow-up periods were 51 months from the first treatment and 23 months from the last one, and these were comparable among treatment groups. CONCLUSIONS: Trigeminal neuralgia can recur after neurosurgical treatment. In this study the authors demonstrate that the number of patients requiring retreatment is not negligible. Lower retreatment rates were seen in patients who initially underwent radiosurgery, compared with those in whom MVD or radiofrequency ablation were performed. Radiosurgery was more likely to be the final treatment for recurrent TN regardless of the initial treatment. After retreatment, the majority of patients attained complete or very good pain relief. Pain relief after retreatment correlates with postoperative facial numbness.

UR - http://www.scopus.com/inward/record.url?scp=33646704975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646704975&partnerID=8YFLogxK

M3 - Article

C2 - 16419977

AN - SCOPUS:33646704975

VL - 18

JO - Neurosurgical Focus

JF - Neurosurgical Focus

SN - 1092-0684

IS - 5

ER -